Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

A Post-Marketing Surveillance Study to Evaluate the Safety Profile of Alvotere ^Ⓡ (Docetaxel) in Iranian Patients Diagnosed with Different Types of Cancers Receiving Chemotherapy.

Autor: Shahi F; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran., Vafaeezadeh F; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran., Ansarinejad N; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran., Ahmadi A; Department of Oncology, School of Medicine, Hamadan University of Medical Sciences, Hamadan, Iran., Shahriari-Ahmadi A; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran., Ghazizadeh A; Medicine Department of Hematology-Medical Oncology, Rafsanjan University of Medical Sciences, Rafsanjan, Iran., Vahedian Ardakani H; Department of Oncology, Medicine Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Ravanbod MR; Department of Hematology and Oncology, Bushehr University of Medical Sciences, Bushehr, Iran., Seifi S; Chronic Respiratory Diseases Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Foratyazdi M; Department of Oncology, Medicine Shahid Sadoughi University of Medical Sciences, Yazd, Iran., Mousavi SA; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran., Rajabi Vahid M; Department of Hematology and Oncology, Zanjan University of Medical Sciences, Zanjan, Iran., Rahimi H; Department of Internal Medicine, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran., Seghatoleslami M; Health research institute, Research Center of Thalassemia & Hemoglobinopathy, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran., Razavi SM; Department of Hematology and Oncology, Iran University of Medical Sciences, Tehran, Iran., Pourkhani AH; Oncology and Hematology, Clinical Research Development Center, Sayad Shirazi Hospital, Golestan University Of Medical Sciences, Gorgan, Iran., Babakhani D; Department of Medical Oncology, Tehran University of Medical Sciences, Tehran, Iran., Anjidani N; Head of Medical Department, Orchid Pharmed Company, Tehran, Iran.

Publikováno v: Current therapeutic research, clinical and experimental [Curr Ther Res Clin Exp] 2021 Dec 16; Vol. 96, pp. 100659. Date of Electronic Publication: 2021 Dec 16 (Print Publication: 2022).